Comparing Pain and Bruising of Subcutaneous Heparin Injection

July 19, 2012 updated by: Tayebe Pourghaznein, Mashhad University of Medical Sciences

Subcutaneous heparin injection is one of the most frequent nurses' clinical care. This study aimed to Identify and compare the effects of four different injection duration on pain and bruising associated with subcutaneous injection of heparin in 90 patients. Four injection methods were used for them:

A: 10s injections duration

B: 10s injection duration and waiting 10s before withdrawing the needle

C: 15s injection duration and waiting 5s before withdrawing the needle

D: 5s injection duration and waiting 15s before withdrawing the needle.

Bruising was measured by a flexible millimeter ruler 48h after each injection; and pain was measured by pain visual analogue scale immediately after the injection. Data will be analyzed by SPSS.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Phase 2
  • Phase 3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

53 years to 69 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Inclination to participate in the study; filling out the form of conscious satisfaction
  • Ability to answer the questions and determining the rate of pain
  • Not being affected by blood clotting difficulties, tissue damages, injuries, and bruises in the site of injection.

Exclusion Criteria:

  • Death,
  • Discharge

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 10s injections duration
Procedure: 10s injections duration
10s injections duration
Experimental: 10s injection duration , waiting 10s
10s injection duration and waiting 10s before withdrawing the needle
Procedure: 10s injection duration and waiting 10s before withdrawing the needle
10s injection duration and waiting 10s before withdrawing the needle
Experimental: 15s injection duration,waiting 5s
15s injection duration and waiting 5s before withdrawing the needle
Procedure: 15s injection duration and waiting 5s before withdrawing the needle
15s injection duration and waiting 5s before withdrawing the needle
Experimental: 5s injection duration , waiting 15s
5s injection duration and waiting 15s before withdrawing the needle
Procedure: 5s injection duration and waiting 15s before withdrawing the needle
5s injection duration and waiting 15s before withdrawing the needle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
decrease pain
Time Frame: up to 6 months
pain was measured by pain visual analogue scale immediately after the injection.
up to 6 months
bruising
Time Frame: up to 6 months
Bruising was measured by a flexible millimeter ruler 48h after each injection
up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mashhad University of Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

May 19, 2012

First Submitted That Met QC Criteria

July 19, 2012

First Posted (Estimate)

July 20, 2012

Study Record Updates

Last Update Posted (Estimate)

July 20, 2012

Last Update Submitted That Met QC Criteria

July 19, 2012

Last Verified

June 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Interventional (Oncolys BioPharma Inc)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on 10s injections duration

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe